日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies

可切除的结肠直肠癌:复发风险、微生物群和液体活检中基因突变检测相关性的当前认识

Andreas Koulouris, Christos Tsagkaris, Ippokratis Messaritakis, Nikolaos Gouvas, Maria Sfakianaki, Maria Trypaki, Vasiliki Spyrou, Manousos Christodoulakis, Elias Athanasakis, Evangelos Xynos, Maria Tzardi, Dimitrios Mavroudis, John Souglakos

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study

PKM2 和 CD44 蛋白表达与铂类治疗的卵巢上皮癌预后不良的相关性:一项回顾性研究

Chara Papadaki, Stavroula Manolakou, Eleni Lagoudaki, Spyros Pontikakis, Despo Ierodiakonou, Konstantinos Vogiatzoglou, Ippokratis Messaritakis, Maria Trypaki, Linda Giannikaki, Maria Sfakianaki, Antonia Kalykaki, Dimitrios Mavroudis, Maria Tzardi, John Souglakos

Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer.

LKB1 蛋白表达的丧失与接受切除术的 II 期或 III 期结肠癌患者的复发和死亡风险增加相关

Sfakianaki Maria, Papadaki Chara, Tzardi Maria, Trypaki Maria, Alam Sardar, Lagoudaki Eleni D, Messaritakis Ippokratis, Zoras Odysseas, Mavroudis Dimitris, Georgoulias Vassilis, Souglakos John

Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients

KRAS、BRAF、PIK3CA 突变、PTEN、AREG、EREG 表达及皮疹对≥2线西妥昔单抗治疗结直肠癌患者的影响

Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, Maria Sfakianaki, Fraga Pega, Aristea Kalikaki, Eleftheria Tsakalaki, Maria Trypaki, Ippokratis Messaritakis, Efstathios Stathopoulos, Dimitris Mavroudis, Vassilis Georgoulias, John Souglakos